Have a personal or library account? Click to login
Water Extract of Tamarix gallica L. as effective Agents against C6 and HeLa tumor cell lines Cover

Water Extract of Tamarix gallica L. as effective Agents against C6 and HeLa tumor cell lines

Open Access
|Nov 2019

Abstract

The aerial parts of Tamarix gallica L. taken from three different climatic stages in Algeria (Oum El Bouaghi: Semi-arid, ElTaref: Humid, and Ouargla: Arid) were extracted using boiling distilled water. The crude extracts were subjected to total phenolics and flavonoids quantifications in addition to anti-proliferative assessment against two tumor cell lines namely rat brain tumor (C6) and human cervix carcinoma (HeLa) using BrdU (bromo-deoxyuridine) ELISA(Enzyme-linked immune-sorbent assay) and xCELLigence assay. The total phenolics yield was found to range between 16.14 and 39.32 mg GAE (Gallic acid equivalent)/g of extract and a flavonoids yield ranging between 16.51 and 20.35 mg QE(quercetin equivalent)/g of extract. The various phenolics were identified using HPLC-TOF/MS to highlight hesperidin and rosmarinic Acid as major components. Moreover, the extracts exhibited different levels of antitumor potency against C6 and HeLa cell lines depending upon the climatic stage and the concentration. A good cytotoxic effect was recorded with the species collected from the humid region at 250 μg/mL. On the contrary, the other extracts revealed a weak activity for both tests.

DOI: https://doi.org/10.2478/asn-2019-0015 | Journal eISSN: 2603-347X | Journal ISSN: 2367-5144
Language: English
Page range: 1 - 13
Published on: Nov 8, 2019
Published by: Konstantin Preslavski University of Shumen
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year

© 2019 Ouroud Fellah, Samir Hameurlaine, Mohamed Djermane, Wafa Tahar, Muhammed Altun, Noureddine Gherraf, Amar Zellagui, Salah Akkal, Abdenabi Abidi, Ali Tahar, Ibrahim Demirtas, Ayse SahinYaglioglu, Gema Nieto, published by Konstantin Preslavski University of Shumen
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.